Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | NAAA | Q02083 | 4/20 | 0.60 |
| ▸ | MLYCD | O95822 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | THRA | P10827 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27117782 | 0.88 | KDM4E (0.51) | L3MBTL1KDM4ESMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL8824851 | 0.85 | L3MBTL1 (0.61) | L3MBTL1NAAAMLYCDCA2KDM4E | |
| SCHEMBL18116704 | 0.85 | KDM4E (0.74) | L3MBTL1NAAAMLYCDCA2KDM4E | |
| SCHEMBL10099583 | 0.85 | KDM4E (0.50) | L3MBTL1NAAAKDM4ESMN1; SMN2NPC1 | |
| SCHEMBL13286818 | 0.84 | KDM4E (0.53) | L3MBTL1KDM4ESMN1; SMN2MEN1MAPT | |
| SCHEMBL12387878 | 0.84 | L3MBTL1 (0.60) | L3MBTL1NAAAMLYCDCA2KDM4E | |
| SCHEMBL31365964 | 0.84 | L3MBTL1 (0.60) | L3MBTL1NAAAMLYCDCA2KDM4E | |
| SCHEMBL9829017 | 0.84 | MAPK1 (0.69) | CA2KDM4ESMN1; SMN2ALDH1A1MAPK1 | |
| SCHEMBL10099585 | 0.84 | MAPK1 (0.69) | CA2KDM4ESMN1; SMN2ALDH1A1MAPK1 | |
| SCHEMBL5426967 | 0.84 | KDM4E (0.76) | L3MBTL1NAAAMLYCDCA2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8093227-B2 | Monosaccharide compounds and methods therefor | ALCHEMIA PTY LTD (AU) | 2012-01-10 | — | — | US | disclosed |
| US-20100184607-A1 | MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR | ALCHEMIA PTY LTD. (AU) | 2010-07-22 | — | — | US | disclosed |
| US-7417129-B2 | Combinatorial libraries of monosaccharides | ALCHEMIA PTY LTD (AU) | 2008-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184607-A1 | MONOSACCHARIDE COMPOUNDS AND METHODS THEREFOR | SLC5A1, UGGT1, MRPL21 | L3MBTL1 2971/4885NAAA 2912/4885MLYCD 584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.